218 related articles for article (PubMed ID: 18569965)
1. Evidence for the use of urinary albumin as marker of kidney involvement in unselected populations.
McQueen MJ
Scand J Clin Lab Invest Suppl; 2008; 241():52-6. PubMed ID: 18569965
[TBL] [Abstract][Full Text] [Related]
2. Twelve shifting paradigms in diabetic renal disease and hypertension.
Mogensen CE
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
[TBL] [Abstract][Full Text] [Related]
3. Microalbuminuria and hypertension.
Reboldi G; Gentile G; Angeli F; Verdecchia P
Minerva Med; 2005 Aug; 96(4):261-75. PubMed ID: 16179893
[TBL] [Abstract][Full Text] [Related]
4. Slowing progression along the renal disease continuum.
Kopyt NP
J Am Osteopath Assoc; 2005 Apr; 105(4):207-15. PubMed ID: 15928338
[TBL] [Abstract][Full Text] [Related]
5. Microalbuminuria as an early marker for cardiovascular disease.
de Zeeuw D; Parving HH; Henning RH
J Am Soc Nephrol; 2006 Aug; 17(8):2100-5. PubMed ID: 16825327
[TBL] [Abstract][Full Text] [Related]
6. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
[TBL] [Abstract][Full Text] [Related]
7. Microalbuminuria and cardiovascular risk.
Karalliedde J; Viberti G
Am J Hypertens; 2004 Oct; 17(10):986-93. PubMed ID: 15485765
[TBL] [Abstract][Full Text] [Related]
8. Microalbuminuria in essential hypertension.
Crippa G
J Hum Hypertens; 2002 Mar; 16 Suppl 1():S74-7. PubMed ID: 11986900
[TBL] [Abstract][Full Text] [Related]
9. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.
Parving HH; Brenner BM; McMurray JJ; de Zeeuw D; Haffner SM; Solomon SD; Chaturvedi N; Ghadanfar M; Weissbach N; Xiang Z; Armbrecht J; Pfeffer MA
Nephrol Dial Transplant; 2009 May; 24(5):1663-71. PubMed ID: 19145003
[TBL] [Abstract][Full Text] [Related]
10. Microalbuminuria as a target to improve cardiovascular and renal outcomes.
Basi S; Lewis JB
Am J Kidney Dis; 2006 Jun; 47(6):927-46. PubMed ID: 16731288
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for the development and progression of renal diseases in disadvantaged populations: role of the renin-angiotensin system blockade.
Maione A; Strippoli GF
Ethn Dis; 2009; 19(1 Suppl 1):S1-86-9. PubMed ID: 19484883
[TBL] [Abstract][Full Text] [Related]
12. Monitoring and managing urinary albumin excretion: practical advice for primary care clinicians.
Bakris GL; Kuritzky L
Postgrad Med; 2009 Jul; 121(4):51-60. PubMed ID: 19641270
[TBL] [Abstract][Full Text] [Related]
13. Urinary albumin and cardiovascular profile in the middle-aged population.
Cirillo M; Lombardi C; Bilancio G; Chiricone D; Stellato D; De Santo NG
Semin Nephrol; 2005 Nov; 25(6):367-71. PubMed ID: 16298257
[TBL] [Abstract][Full Text] [Related]
14. Mediators of target organ damage in hypertension: focus on obesity associated factors and inflammation.
Dawood T; Schlaich MP
Minerva Cardioangiol; 2009 Dec; 57(6):687-704. PubMed ID: 19942842
[TBL] [Abstract][Full Text] [Related]
15. The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality.
Klausen KP; Parving HH; Scharling H; Jensen JS
J Intern Med; 2007 Oct; 262(4):470-8. PubMed ID: 17875184
[TBL] [Abstract][Full Text] [Related]
16. The progressive pathway of microalbuminuria: from early marker of renal damage to strong cardiovascular risk predictor.
Cerasola G; Cottone S; Mulè G
J Hypertens; 2010 Dec; 28(12):2357-69. PubMed ID: 20842046
[TBL] [Abstract][Full Text] [Related]
17. Microalbuminuria: do we need a new threshold?
Zamora CR; Cubeddu LX
J Hum Hypertens; 2009 Feb; 23(2):146-9. PubMed ID: 18784737
[TBL] [Abstract][Full Text] [Related]
18. Chronic kidney disease as a situation of high added risk in hypertensive patients.
Segura J; García-Donaire JA; Praga M; Ruilope LM
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S136-40. PubMed ID: 16565238
[TBL] [Abstract][Full Text] [Related]
19. Renal disease: a common and a silent killer.
de Zeeuw D
Nat Clin Pract Cardiovasc Med; 2008 Jul; 5 Suppl 1():S27-35. PubMed ID: 18580863
[TBL] [Abstract][Full Text] [Related]
20. Update on microalbuminuria as a biomarker in renal and cardiovascular disease.
Lambers Heerspink HJ; Brinkman JW; Bakker SJ; Gansevoort RT; de Zeeuw D
Curr Opin Nephrol Hypertens; 2006 Nov; 15(6):631-6. PubMed ID: 17053479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
